Patents by Inventor JUDITH GIROUD-GERBETANT

JUDITH GIROUD-GERBETANT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230133114
    Abstract: The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of promoting protective immunity and/or for preventing and/or treating bacterial or viral infections and/or for limiting immune mediated pathology following infection in an individual comprising delivering to the individual in need an effective unit dose form of reduced nicotinamide.
    Type: Application
    Filed: March 9, 2021
    Publication date: May 4, 2023
    Inventors: CARLES CANTO ALVAREZ, STEFAN CHRISTEN, MARIA PILAR GINER, JUDITH GIROUD-GERBETANT, SOFIA MOCO, CHEONG KWET CHOY KWONG CHUNG, ELEONORA CIARLO
  • Publication number: 20230119002
    Abstract: The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of cardiovascular disease and/or conditions. In one embodiment of the invention, said compounds and compositions of the invention maintain or improve cardiovascular tissue and cellular function. In another embodiment of the invention, said compounds and compositions of the invention enhance cardiovascular recovery after injury or surgery.
    Type: Application
    Filed: March 9, 2021
    Publication date: April 20, 2023
    Inventors: CARLES CANTO ALVAREZ, STEFAN CHRISTEN, MARIA PILAR GINER, JUDITH GIROUD-GERBETANT, SOFIA MOCO, PHILIPP GUT, MAGALI JOFFRAUD, JOY RICHARD
  • Publication number: 20230114280
    Abstract: The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of neurological disease and/or conditions. In one embodiment of the invention, said compounds and compositions of the invention maintain or improve brain function, in particular brain energy deficits. In another embodiment of the invention, compounds and compositions of the invention improve neurological recovery and regeneration after injury or surgery. In another embodiment of the invention, compounds and compositions of the invention may be used in methods to prevent and/or treat neurological diseases and/or conditions and/or recovery after injury or surgery.
    Type: Application
    Filed: March 9, 2021
    Publication date: April 13, 2023
    Inventors: CARLES CANTO ALVAREZ, STEFAN CHRISTEN, MARIA PILAR GINER, JUDITH GIROUD-GERBETANT, MAGALI JOFFRAUD, SOFIA MOCO
  • Publication number: 20230095103
    Abstract: The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of lung disease and/or conditions. In one embodiment of the invention, said compounds and compositions of the invention improve the lung by maintaining or improving lung function. In another embodiment of the invention, the compounds and compositions of the invention improve lung recovery and regeneration after injury or surgery.
    Type: Application
    Filed: March 9, 2021
    Publication date: March 30, 2023
    Inventors: CARLES CANTO ALVAREZ, STEFAN CHRISTEN, MARIA PILAR GINER, JUDITH GIROUD-GERBETANT, SOFIA MOCO, CHEONG KWET CHOY KWONG CHUNG
  • Publication number: 20220323468
    Abstract: The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of liver disease and/or conditions. In one embodiment of the invention, said compounds and compositions of the invention improve liver by maintaining or improving liver function; maintaining or improving hepatocyte function; and improving liver recovery and regeneration after injury, transplantation or surgery. In another embodiment of the invention, compounds and compositions of the invention may be used in methods to prevent and/or treat liver diseases and/or conditions such as: non-alcoholic fatty liver disease (NAFLD), alcoholic fatty liver disease, hepatic steatosis, cirrhosis and/or recovery and regeneration after liver injury, transplantation or surgery.
    Type: Application
    Filed: June 3, 2020
    Publication date: October 13, 2022
    Inventors: CARLES CANTO ALVAREZ, STEFAN CHRISTEN, MARIA PILAR GINER, JUDITH GIROUD-GERBETANT, SOFIA MOCO, MARIE MIGAUD
  • Publication number: 20220296623
    Abstract: The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of kidney diseases and conditions. In one embodiment of the invention, said compounds and compositions of the invention improve kidney function by reducing formation of kidney cysts, reducing glomerule dilatation, reducing renal cell apoptosis and preventing increases in blood urea nitrogen. In another embodiment of the invention, compounds and compositions of the invention may be used in methods to prevent and/or treat acute kidney injury (AKI), chronic kidney disease, diabetic nephropathy, focal segmental glomerulosclerosis, nephrotic syndrome, renal fibrosis and kidney cancer.
    Type: Application
    Filed: June 3, 2020
    Publication date: September 22, 2022
    Inventors: CARLES CANTO ALVAREZ, STEFAN CHRISTEN, MARIA PILAR GINER, JUDITH GIROUD-GERBETANT, SOFIA MOCO, SIMONA BARTOVA, MARIE MIGAUD
  • Publication number: 20220233565
    Abstract: The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of skeletal muscle disease and/or conditions. In one embodiment of the invention, said compounds and compositions of the invention improve skeletal muscle by maintaining or improving muscle function; maintaining or increasing muscle mass; maintaining or improving muscle strength; and improving muscle recovery and regeneration after injury or surgery. In another embodiment of the invention, compounds and compositions of the invention may be used in methods to prevent and/or treat skeletal muscle diseases and/or conditions such as: cachexia or precachexia; sarcopenia, myopathy, dystrophy, and/or recovery after intense exercise, muscle injury or surgery.
    Type: Application
    Filed: June 3, 2020
    Publication date: July 28, 2022
    Inventors: CARLES CANTO ALVAREZ, STEFAN CHRISTEN, MARIA PILAR GINER, JUDITH GIROUD-GERBETANT, SOFIA MOCO